Zura Bio LimitedZURA

$3.75+0.13 (+3.59%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$421M

Small-cap

+281%

2023 — today

10-Year Price

-41%

2023 — today

52-Week Range

$1.05$7.04

Current $3.75· 45%

Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.

Valuation in context

P/E ratio

-3.4

N/A

Not meaningful — company is unprofitable

P/B ratio

1.9

Below average

Below the 10-year average

FCF Yield

-17.3%

Below average

Below the 10-year average

Free · No credit card needed

Get alerted when ZURA is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.